Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents.
Iorio
A
A
Sezione di Medicina Interna e Cardiovascolare, Università di Perugia, Perugia, Italy. iorioa@unipg.it
D001384:Azetidines; D001596:Benzylamines; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight; D006801:Humans; D019637:Orthopedic Procedures / Q000009:adverse effects*; D011183:Postoperative Complications / Q000517:prevention & control; D013810:Therapeutic Equivalency; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D001384:Azetidines; D001596:Benzylamines; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; C426686:ximelagatran